Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methylphenidate hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tuzulby 20mg prolonged-release chewable tablets
0404000M0BRAABD
|
Tuzulby | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Tuzulby 30mg prolonged-release chewable tablets
0404000M0BRABBE
|
Tuzulby | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Tuzulby 40mg prolonged-release chewable tablets
0404000M0BRACBF
|
Tuzulby | Methylphenidate hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.